| Dr Ernest Littleton Park Jr, MD | |
|
207 Annandale Cres, Birmingham, AL 35223-2901 | |
| (205) 967-6396 | |
| Not Available |
| Full Name | Dr Ernest Littleton Park Jr |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 207 Annandale Cres, Birmingham, Alabama |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1487821369 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 2908 (Alabama) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ernest Littleton Park Jr, MD 207 Annandale Cres, Birmingham, AL 35223-2901 Ph: (205) 967-6396 | Dr Ernest Littleton Park Jr, MD 207 Annandale Cres, Birmingham, AL 35223-2901 Ph: (205) 967-6396 |
News Archive
Vermillion, Inc., a molecular diagnostics company, today announced that the United States Patent and Trademark Office has issued a notice of allowance for a patent entitled "Panel of Biomarkers for Peripheral Artery Disease" to the company.
A new, continuous flow heart pump, or left ventricular assist device (LVAD), delivered better two-year survival in advanced heart failure patients than the current pulsatile model, researchers reported in a late-breaking clinical trial presentation at the American Heart Association's Scientific Sessions 2009.
Cancer-related fatigue is often a major problem for cancer patients, beginning at diagnosis, during treatment and after completing therapy. Researchers at Mayo Clinic and the North Central Cancer Treatment Group (NCCTG) recently completed a study testing methylphenidate in the treatment of cancer-related fatigue and found that, while it did not improve fatigue for a broad group of patients, the data did not rule out a benefit for those with stage III/IV cancer.
As part of a multicenter study, UT Southwestern Medical Center researchers have identified a series of chemical compounds that might serve as starting points for the identification of new classes of anti-malarial drugs.
Patients with diabetic macular oedema have smaller choroidal thickness measurements in affected and unaffected eyes compared with healthy individuals, spectral-domain optical coherence tomography imaging results reveal.
› Verified 2 days ago
Rayford W Thweatt, Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 619 19th Street South, Birmingham, AL 35233 Phone: 205-934-6600 | |
Marla B Morgan, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 619 19th Street South, Birmingham, AL 35233 Phone: 205-934-6600 | |
Robins J Newton, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2700 10th Ave S Ste 400, Birmingham, AL 35205 Phone: 205-918-0507 Fax: 205-930-2716 | |
Mohamed Kazamel, Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1717 6th Ave S, Birmingham, AL 35233 Phone: 800-822-8816 | |
Dr. Rodney K Swillie, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 3686 Grandview Pkwy Ste 600, Birmingham, AL 35243 Phone: 205-971-3600 Fax: 844-772-0468 | |
Sandra L Frazier, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 619 19t Street South, Birmingham, AL 35233 Phone: 205-934-6600 | |
Michael Alonzo Lopez, M.D., PH.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1600 6th Ave S # Chb314, Birmingham, AL 35233 Phone: 205-996-7850 |